. Kattan MW Nomograms. Introduction. Semin Urol Oncol 20: 7981. six. Kattan MW, Wheeler TM, Scardino PT Postoperative 548-04-9 web nomogram for illness recurrence just after radical prostatectomy for prostate cancer. J Clin Oncol 17: 14991507. 7. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence soon after radical prostatectomy. Journal of Clinical Oncology 23: 7005 7012. eight. Kattan MW, Vickers AJ, Yu CH, Bianco FJ, Cronin AM, et al. Preoperative and Postoperative Nomograms Incorporating Surgeon Encounter for Clinically Localized Prostate Cancer. Cancer 115: 10051010. 9. Swanson GP, Yu CH, Kattan MW, Hermans MR Validation of Postoperative Nomograms in Prostate Cancer Patients with Long-term Followup. Urology 78: 105109. ten. Agus DB, Sweeney CJ, Morris MJ, Mendelson DS, McNeel DG, et al. Efficacy and security of single-agent pertuzumab, a human epidermal growth issue receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. J Clin Oncol 25: 
675681. 11. Jia Z, Yipeng Wang, Anne Sawyers, Huazhen Yao, Farahnaz Rahmatpanah, Xiao-Qin Xia, Qiang Xu, Rebecca Pio, Tolga Turan, James A.. Koziol, Stephen Goodison, Philip Carpenter, Jessica Wang-Rodriquez, Anne Simoneau, Frank Meyskens, Manuel Sutton, Waldemar Lernhardt, Thomas Beach, Joseph Monforte, Michael McClelland and Dan Mercola contributed equally Diagnosis of Prostate Cancer Working with Differentially Expressed Genes in Stroma.. Cancer Research 71: 24762487. 12. Wang Y, Xia XQ, Jia Z, Sawyers A, Yao H, et al. In silico Estimates of Tissue Elements in Surgical Samples Based on Expression Profiling Information. Cancer Res 70: 64486455. 13. Chen X, Xu S, McClelland M, Rahmatpanah F, Sawyers A, et al. An precise prostate cancer prognosticator working with a seven-gene 56-59-7 site Signature plus Gleason score and taking cell type heterogeneity into account. PLoS A single 7: e45178. 14. Jia Z, Rahmatpanah FB, Chen X, Lernhardt W, Wang Y, et al. Expression changes inside the stroma of prostate cancer predict subsequent relapse. PLoS One 7: e41371. 15. Jia Z, Wang Y, Hu Y, McLaren C, Yu Y, et al. A Sample Selection Strategy to Boost the Statistical Energy of Signature Detection in Cancer Expression Profile Research. Anticancer Agents Med Chem. 16. Ebrahimi 23148522 K, Ruckle H, Harper JD, Ornstein DK, Ahlering TE, et al. Post prostatectomy multimodality adjuvant therapy for 
patients at high risk for prostate cancer relapse. Journal of Urology 179: 558559. 17. Petrylak DP, Macarthur R, O’Connor J, Shelton G, Weitzman A, et al. Phase I/II research of docetaxel combined with estramustine in males with hormone-refractory prostate cancer. Seminars in Oncology 26: 2833. 18. Cleveland WS Robust Locally Weighted Regression and Smoothing Scatterplots. Journal from the American Statistical Association 74: 829836. 19. Cleveland WS Lowess – a Program for Smoothing Scatterplots by Robust Locally Weighted Regression. American Statistician 35: 5454. 20. Schoenberg IJ Contributions for the Trouble of Approximation of Equidistant Data by Analytic Functions. B. On the Issue of Osculatory Interpolation – a 2nd Class of Analytic Approximation Formulae. Quarterly of Applied Mathematics four: 112141. 21. Kaplan EL, Meier P Nonparametric-Estimation from Incomplete Observations. Journal with the American Statistical Association 53: 457481. 22. Cantor AB Energy calculation for the log rank test working with historical information. Manage Clin Trials 17: 1.. Kattan MW Nomograms. Introduction. Semin Urol Oncol 20: 7981. 6. Kattan MW, Wheeler TM, Scardino PT Postoperative nomogram for disease recurrence right after radical prostatectomy for prostate cancer. J Clin Oncol 17: 14991507. 7. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence right after radical prostatectomy. Journal of Clinical Oncology 23: 7005 7012. 8. Kattan MW, Vickers AJ, Yu CH, Bianco FJ, Cronin AM, et al. Preoperative and Postoperative Nomograms Incorporating Surgeon Knowledge for Clinically Localized Prostate Cancer. Cancer 115: 10051010. 9. Swanson GP, Yu CH, Kattan MW, Hermans MR Validation of Postoperative Nomograms in Prostate Cancer Sufferers with Long-term Followup. Urology 78: 105109. ten. Agus DB, Sweeney CJ, Morris MJ, Mendelson DS, McNeel DG, et al. Efficacy and safety of single-agent pertuzumab, a human epidermal growth element receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. J Clin Oncol 25: 675681. 11. Jia Z, Yipeng Wang, Anne Sawyers, Huazhen Yao, Farahnaz Rahmatpanah, Xiao-Qin Xia, Qiang Xu, Rebecca Pio, Tolga Turan, James A.. Koziol, Stephen Goodison, Philip Carpenter, Jessica Wang-Rodriquez, Anne Simoneau, Frank Meyskens, Manuel Sutton, Waldemar Lernhardt, Thomas Beach, Joseph Monforte, Michael McClelland and Dan Mercola contributed equally Diagnosis of Prostate Cancer Working with Differentially Expressed Genes in Stroma.. Cancer Research 71: 24762487. 12. Wang Y, Xia XQ, Jia Z, Sawyers A, Yao H, et al. In silico Estimates of Tissue Elements in Surgical Samples Based on Expression Profiling Data. Cancer Res 70: 64486455. 13. Chen X, Xu S, McClelland M, Rahmatpanah F, Sawyers A, et al. An correct prostate cancer prognosticator working with a seven-gene signature plus Gleason score and taking cell variety heterogeneity into account. PLoS One 7: e45178. 14. Jia Z, Rahmatpanah FB, Chen X, Lernhardt W, Wang Y, et al. Expression changes in the stroma of prostate cancer predict subsequent relapse. PLoS One 7: e41371. 15. Jia Z, Wang Y, Hu Y, McLaren C, Yu Y, et al. A Sample Selection Tactic to Enhance the Statistical Energy of Signature Detection in Cancer Expression Profile Studies. Anticancer Agents Med Chem. 16. Ebrahimi 23148522 K, Ruckle H, Harper JD, Ornstein DK, Ahlering TE, et al. Post prostatectomy multimodality adjuvant therapy for patients at higher risk for prostate cancer relapse. Journal of Urology 179: 558559. 17. Petrylak DP, Macarthur R, O’Connor J, Shelton G, Weitzman A, et al. Phase I/II studies of docetaxel combined with estramustine in men with hormone-refractory prostate cancer. Seminars in Oncology 26: 2833. 18. Cleveland WS Robust Locally Weighted Regression and Smoothing Scatterplots. Journal of the American Statistical Association 74: 829836. 19. Cleveland WS Lowess – a Plan for Smoothing Scatterplots by Robust Locally Weighted Regression. American Statistician 35: 5454. 20. Schoenberg IJ Contributions to the Dilemma of Approximation of Equidistant Data by Analytic Functions. B. On the Problem of Osculatory Interpolation – a 2nd Class of Analytic Approximation Formulae. Quarterly of Applied Mathematics 4: 112141. 21. Kaplan EL, Meier P Nonparametric-Estimation from Incomplete Observations. Journal from the American Statistical Association 53: 457481. 22. Cantor AB Power calculation for the log rank test utilizing historical information. Control Clin Trials 17: 1.
